Research programme: cancer therapeutics - Goff Hill
Latest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator Goff Hill
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Barbados
- 06 Jan 2012 Research programme: cancer therapeutics - Goff Hill is available for licensing as of 06 Jan 2012. http://www.goffhillltd.com/
- 06 Jan 2012 Preclinical trials in Cancer in Barbados (unspecified route)